Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
IBS-C Drugs market report explains the definition, types, applications, major countries, and major players of the IBS-C Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Ardelyx Inc
Synthetic Biologics Inc
Abbott Laboratories
Ferring BV
Actavis Nordic A/S
Bama-Geve, SLU
Sucampo Pharmaceuticals
Ono Pharmaceutical CO LTD
Salix Pharmaceuticals Ltd
Astellas Pharmaceuticals
Teva Pharmaceutical Industries
Prometheus Laboratories Inc
Yuhan Corp
Norgine BV
Astrazeneca Plc
Ironwood Pharmaceuticals Inc
Catalent Pharmaceuticals Solutions
The Menarini Group
Novartis Pharma Ag
Nestle
Albireo Pharma Inc
Synergy Pharmaceuticals
By Type:
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Other
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global IBS-C Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 IBS-C Drugs Outlook to 2028- Original Forecasts
-
2.2 IBS-C Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term IBS-C Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global IBS-C Drugs Market- Recent Developments
-
6.1 IBS-C Drugs Market News and Developments
-
6.2 IBS-C Drugs Market Deals Landscape
7 IBS-C Drugs Raw Materials and Cost Structure Analysis
-
7.1 IBS-C Drugs Key Raw Materials
-
7.2 IBS-C Drugs Price Trend of Key Raw Materials
-
7.3 IBS-C Drugs Key Suppliers of Raw Materials
-
7.4 IBS-C Drugs Market Concentration Rate of Raw Materials
-
7.5 IBS-C Drugs Cost Structure Analysis
-
7.5.1 IBS-C Drugs Raw Materials Analysis
-
7.5.2 IBS-C Drugs Labor Cost Analysis
-
7.5.3 IBS-C Drugs Manufacturing Expenses Analysis
8 Global IBS-C Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global IBS-C Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global IBS-C Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global IBS-C Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global IBS-C Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Linaclotide Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Lubiprostone Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Osmotic Laxatives Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Stimulant Laxatives Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global IBS-C Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Region and Country-wise IBS-C Drugs Market Analysis and Outlook till 2022
-
10.1 Global IBS-C Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States IBS-C Drugs Consumption (2017-2022)
-
10.2.2 Canada IBS-C Drugs Consumption (2017-2022)
-
10.2.3 Mexico IBS-C Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany IBS-C Drugs Consumption (2017-2022)
-
10.3.2 UK IBS-C Drugs Consumption (2017-2022)
-
10.3.3 Spain IBS-C Drugs Consumption (2017-2022)
-
10.3.4 Belgium IBS-C Drugs Consumption (2017-2022)
-
10.3.5 France IBS-C Drugs Consumption (2017-2022)
-
10.3.6 Italy IBS-C Drugs Consumption (2017-2022)
-
10.3.7 Denmark IBS-C Drugs Consumption (2017-2022)
-
10.3.8 Finland IBS-C Drugs Consumption (2017-2022)
-
10.3.9 Norway IBS-C Drugs Consumption (2017-2022)
-
10.3.10 Sweden IBS-C Drugs Consumption (2017-2022)
-
10.3.11 Poland IBS-C Drugs Consumption (2017-2022)
-
10.3.12 Russia IBS-C Drugs Consumption (2017-2022)
-
10.3.13 Turkey IBS-C Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China IBS-C Drugs Consumption (2017-2022)
-
10.4.2 Japan IBS-C Drugs Consumption (2017-2022)
-
10.4.3 India IBS-C Drugs Consumption (2017-2022)
-
10.4.4 South Korea IBS-C Drugs Consumption (2017-2022)
-
10.4.5 Pakistan IBS-C Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh IBS-C Drugs Consumption (2017-2022)
-
10.4.7 Indonesia IBS-C Drugs Consumption (2017-2022)
-
10.4.8 Thailand IBS-C Drugs Consumption (2017-2022)
-
10.4.9 Singapore IBS-C Drugs Consumption (2017-2022)
-
10.4.10 Malaysia IBS-C Drugs Consumption (2017-2022)
-
10.4.11 Philippines IBS-C Drugs Consumption (2017-2022)
-
10.4.12 Vietnam IBS-C Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil IBS-C Drugs Consumption (2017-2022)
-
10.5.2 Colombia IBS-C Drugs Consumption (2017-2022)
-
10.5.3 Chile IBS-C Drugs Consumption (2017-2022)
-
10.5.4 Argentina IBS-C Drugs Consumption (2017-2022)
-
10.5.5 Venezuela IBS-C Drugs Consumption (2017-2022)
-
10.5.6 Peru IBS-C Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico IBS-C Drugs Consumption (2017-2022)
-
10.5.8 Ecuador IBS-C Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain IBS-C Drugs Consumption (2017-2022)
-
10.6.2 Kuwait IBS-C Drugs Consumption (2017-2022)
-
10.6.3 Oman IBS-C Drugs Consumption (2017-2022)
-
10.6.4 Qatar IBS-C Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia IBS-C Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates IBS-C Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria IBS-C Drugs Consumption (2017-2022)
-
10.7.2 South Africa IBS-C Drugs Consumption (2017-2022)
-
10.7.3 Egypt IBS-C Drugs Consumption (2017-2022)
-
10.7.4 Algeria IBS-C Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia IBS-C Drugs Consumption (2017-2022)
-
10.8.2 New Zealand IBS-C Drugs Consumption (2017-2022)
11 Global IBS-C Drugs Competitive Analysis
-
11.1 Ardelyx Inc
-
11.1.1 Ardelyx Inc Company Details
-
11.1.2 Ardelyx Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Ardelyx Inc IBS-C Drugs Main Business and Markets Served
-
11.1.4 Ardelyx Inc IBS-C Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Synthetic Biologics Inc
-
11.2.1 Synthetic Biologics Inc Company Details
-
11.2.2 Synthetic Biologics Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Synthetic Biologics Inc IBS-C Drugs Main Business and Markets Served
-
11.2.4 Synthetic Biologics Inc IBS-C Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Abbott Laboratories
-
11.3.1 Abbott Laboratories Company Details
-
11.3.2 Abbott Laboratories IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Abbott Laboratories IBS-C Drugs Main Business and Markets Served
-
11.3.4 Abbott Laboratories IBS-C Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Ferring BV
-
11.4.1 Ferring BV Company Details
-
11.4.2 Ferring BV IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Ferring BV IBS-C Drugs Main Business and Markets Served
-
11.4.4 Ferring BV IBS-C Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Actavis Nordic A/S
-
11.5.1 Actavis Nordic A/S Company Details
-
11.5.2 Actavis Nordic A/S IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Actavis Nordic A/S IBS-C Drugs Main Business and Markets Served
-
11.5.4 Actavis Nordic A/S IBS-C Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Bama-Geve, SLU
-
11.6.1 Bama-Geve, SLU Company Details
-
11.6.2 Bama-Geve, SLU IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Bama-Geve, SLU IBS-C Drugs Main Business and Markets Served
-
11.6.4 Bama-Geve, SLU IBS-C Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Sucampo Pharmaceuticals
-
11.7.1 Sucampo Pharmaceuticals Company Details
-
11.7.2 Sucampo Pharmaceuticals IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Sucampo Pharmaceuticals IBS-C Drugs Main Business and Markets Served
-
11.7.4 Sucampo Pharmaceuticals IBS-C Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Ono Pharmaceutical CO LTD
-
11.8.1 Ono Pharmaceutical CO LTD Company Details
-
11.8.2 Ono Pharmaceutical CO LTD IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Ono Pharmaceutical CO LTD IBS-C Drugs Main Business and Markets Served
-
11.8.4 Ono Pharmaceutical CO LTD IBS-C Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Salix Pharmaceuticals Ltd
-
11.9.1 Salix Pharmaceuticals Ltd Company Details
-
11.9.2 Salix Pharmaceuticals Ltd IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Salix Pharmaceuticals Ltd IBS-C Drugs Main Business and Markets Served
-
11.9.4 Salix Pharmaceuticals Ltd IBS-C Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Astellas Pharmaceuticals
-
11.10.1 Astellas Pharmaceuticals Company Details
-
11.10.2 Astellas Pharmaceuticals IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Astellas Pharmaceuticals IBS-C Drugs Main Business and Markets Served
-
11.10.4 Astellas Pharmaceuticals IBS-C Drugs Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Teva Pharmaceutical Industries
-
11.11.1 Teva Pharmaceutical Industries Company Details
-
11.11.2 Teva Pharmaceutical Industries IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Teva Pharmaceutical Industries IBS-C Drugs Main Business and Markets Served
-
11.11.4 Teva Pharmaceutical Industries IBS-C Drugs Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Prometheus Laboratories Inc
-
11.12.1 Prometheus Laboratories Inc Company Details
-
11.12.2 Prometheus Laboratories Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Prometheus Laboratories Inc IBS-C Drugs Main Business and Markets Served
-
11.12.4 Prometheus Laboratories Inc IBS-C Drugs Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Yuhan Corp
-
11.13.1 Yuhan Corp Company Details
-
11.13.2 Yuhan Corp IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Yuhan Corp IBS-C Drugs Main Business and Markets Served
-
11.13.4 Yuhan Corp IBS-C Drugs Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Norgine BV
-
11.14.1 Norgine BV Company Details
-
11.14.2 Norgine BV IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Norgine BV IBS-C Drugs Main Business and Markets Served
-
11.14.4 Norgine BV IBS-C Drugs Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Astrazeneca Plc
-
11.15.1 Astrazeneca Plc Company Details
-
11.15.2 Astrazeneca Plc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Astrazeneca Plc IBS-C Drugs Main Business and Markets Served
-
11.15.4 Astrazeneca Plc IBS-C Drugs Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Ironwood Pharmaceuticals Inc
-
11.16.1 Ironwood Pharmaceuticals Inc Company Details
-
11.16.2 Ironwood Pharmaceuticals Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Ironwood Pharmaceuticals Inc IBS-C Drugs Main Business and Markets Served
-
11.16.4 Ironwood Pharmaceuticals Inc IBS-C Drugs Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Catalent Pharmaceuticals Solutions
-
11.17.1 Catalent Pharmaceuticals Solutions Company Details
-
11.17.2 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Main Business and Markets Served
-
11.17.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 The Menarini Group
-
11.18.1 The Menarini Group Company Details
-
11.18.2 The Menarini Group IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 The Menarini Group IBS-C Drugs Main Business and Markets Served
-
11.18.4 The Menarini Group IBS-C Drugs Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Novartis Pharma Ag
-
11.19.1 Novartis Pharma Ag Company Details
-
11.19.2 Novartis Pharma Ag IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Novartis Pharma Ag IBS-C Drugs Main Business and Markets Served
-
11.19.4 Novartis Pharma Ag IBS-C Drugs Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Nestle
-
11.20.1 Nestle Company Details
-
11.20.2 Nestle IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Nestle IBS-C Drugs Main Business and Markets Served
-
11.20.4 Nestle IBS-C Drugs Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Albireo Pharma Inc
-
11.21.1 Albireo Pharma Inc Company Details
-
11.21.2 Albireo Pharma Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Albireo Pharma Inc IBS-C Drugs Main Business and Markets Served
-
11.21.4 Albireo Pharma Inc IBS-C Drugs Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 Synergy Pharmaceuticals
-
11.22.1 Synergy Pharmaceuticals Company Details
-
11.22.2 Synergy Pharmaceuticals IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 Synergy Pharmaceuticals IBS-C Drugs Main Business and Markets Served
-
11.22.4 Synergy Pharmaceuticals IBS-C Drugs Product Portfolio
-
11.22.5 Recent Research and Development Strategies
12 Global IBS-C Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global IBS-C Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Linaclotide Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Lubiprostone Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Osmotic Laxatives Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Stimulant Laxatives Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global IBS-C Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise IBS-C Drugs Market Analysis and Outlook to 2028
-
13.1 Global IBS-C Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States IBS-C Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada IBS-C Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico IBS-C Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany IBS-C Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK IBS-C Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain IBS-C Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium IBS-C Drugs Consumption Forecast (2022-2028)
-
13.3.5 France IBS-C Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy IBS-C Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark IBS-C Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland IBS-C Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway IBS-C Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden IBS-C Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland IBS-C Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia IBS-C Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey IBS-C Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China IBS-C Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan IBS-C Drugs Consumption Forecast (2022-2028)
-
13.4.3 India IBS-C Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea IBS-C Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan IBS-C Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh IBS-C Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia IBS-C Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand IBS-C Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore IBS-C Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia IBS-C Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines IBS-C Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam IBS-C Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil IBS-C Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia IBS-C Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile IBS-C Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina IBS-C Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela IBS-C Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru IBS-C Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico IBS-C Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador IBS-C Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain IBS-C Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait IBS-C Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman IBS-C Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar IBS-C Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia IBS-C Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates IBS-C Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria IBS-C Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa IBS-C Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt IBS-C Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria IBS-C Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia IBS-C Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand IBS-C Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of IBS-C Drugs
-
Figure of IBS-C Drugs Picture
-
Table Global IBS-C Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global IBS-C Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Linaclotide Consumption and Growth Rate (2017-2022)
-
Figure Global Lubiprostone Consumption and Growth Rate (2017-2022)
-
Figure Global Osmotic Laxatives Consumption and Growth Rate (2017-2022)
-
Figure Global Stimulant Laxatives Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global IBS-C Drugs Consumption by Country (2017-2022)
-
Table North America IBS-C Drugs Consumption by Country (2017-2022)
-
Figure United States IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe IBS-C Drugs Consumption by Country (2017-2022)
-
Figure Germany IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure France IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC IBS-C Drugs Consumption by Country (2017-2022)
-
Figure China IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure India IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Table South America IBS-C Drugs Consumption by Country (2017-2022)
-
Figure Brazil IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC IBS-C Drugs Consumption by Country (2017-2022)
-
Figure Bahrain IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa IBS-C Drugs Consumption by Country (2017-2022)
-
Figure Nigeria IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania IBS-C Drugs Consumption by Country (2017-2022)
-
Figure Australia IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand IBS-C Drugs Consumption and Growth Rate (2017-2022)
-
Table Ardelyx Inc Company Details
-
Table Ardelyx Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ardelyx Inc IBS-C Drugs Main Business and Markets Served
-
Table Ardelyx Inc IBS-C Drugs Product Portfolio
-
Table Synthetic Biologics Inc Company Details
-
Table Synthetic Biologics Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synthetic Biologics Inc IBS-C Drugs Main Business and Markets Served
-
Table Synthetic Biologics Inc IBS-C Drugs Product Portfolio
-
Table Abbott Laboratories Company Details
-
Table Abbott Laboratories IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories IBS-C Drugs Main Business and Markets Served
-
Table Abbott Laboratories IBS-C Drugs Product Portfolio
-
Table Ferring BV Company Details
-
Table Ferring BV IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ferring BV IBS-C Drugs Main Business and Markets Served
-
Table Ferring BV IBS-C Drugs Product Portfolio
-
Table Actavis Nordic A/S Company Details
-
Table Actavis Nordic A/S IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actavis Nordic A/S IBS-C Drugs Main Business and Markets Served
-
Table Actavis Nordic A/S IBS-C Drugs Product Portfolio
-
Table Bama-Geve, SLU Company Details
-
Table Bama-Geve, SLU IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bama-Geve, SLU IBS-C Drugs Main Business and Markets Served
-
Table Bama-Geve, SLU IBS-C Drugs Product Portfolio
-
Table Sucampo Pharmaceuticals Company Details
-
Table Sucampo Pharmaceuticals IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sucampo Pharmaceuticals IBS-C Drugs Main Business and Markets Served
-
Table Sucampo Pharmaceuticals IBS-C Drugs Product Portfolio
-
Table Ono Pharmaceutical CO LTD Company Details
-
Table Ono Pharmaceutical CO LTD IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ono Pharmaceutical CO LTD IBS-C Drugs Main Business and Markets Served
-
Table Ono Pharmaceutical CO LTD IBS-C Drugs Product Portfolio
-
Table Salix Pharmaceuticals Ltd Company Details
-
Table Salix Pharmaceuticals Ltd IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Salix Pharmaceuticals Ltd IBS-C Drugs Main Business and Markets Served
-
Table Salix Pharmaceuticals Ltd IBS-C Drugs Product Portfolio
-
Table Astellas Pharmaceuticals Company Details
-
Table Astellas Pharmaceuticals IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astellas Pharmaceuticals IBS-C Drugs Main Business and Markets Served
-
Table Astellas Pharmaceuticals IBS-C Drugs Product Portfolio
-
Table Teva Pharmaceutical Industries Company Details
-
Table Teva Pharmaceutical Industries IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries IBS-C Drugs Main Business and Markets Served
-
Table Teva Pharmaceutical Industries IBS-C Drugs Product Portfolio
-
Table Prometheus Laboratories Inc Company Details
-
Table Prometheus Laboratories Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prometheus Laboratories Inc IBS-C Drugs Main Business and Markets Served
-
Table Prometheus Laboratories Inc IBS-C Drugs Product Portfolio
-
Table Yuhan Corp Company Details
-
Table Yuhan Corp IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Yuhan Corp IBS-C Drugs Main Business and Markets Served
-
Table Yuhan Corp IBS-C Drugs Product Portfolio
-
Table Norgine BV Company Details
-
Table Norgine BV IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Norgine BV IBS-C Drugs Main Business and Markets Served
-
Table Norgine BV IBS-C Drugs Product Portfolio
-
Table Astrazeneca Plc Company Details
-
Table Astrazeneca Plc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astrazeneca Plc IBS-C Drugs Main Business and Markets Served
-
Table Astrazeneca Plc IBS-C Drugs Product Portfolio
-
Table Ironwood Pharmaceuticals Inc Company Details
-
Table Ironwood Pharmaceuticals Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ironwood Pharmaceuticals Inc IBS-C Drugs Main Business and Markets Served
-
Table Ironwood Pharmaceuticals Inc IBS-C Drugs Product Portfolio
-
Table Catalent Pharmaceuticals Solutions Company Details
-
Table Catalent Pharmaceuticals Solutions IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Catalent Pharmaceuticals Solutions IBS-C Drugs Main Business and Markets Served
-
Table Catalent Pharmaceuticals Solutions IBS-C Drugs Product Portfolio
-
Table The Menarini Group Company Details
-
Table The Menarini Group IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table The Menarini Group IBS-C Drugs Main Business and Markets Served
-
Table The Menarini Group IBS-C Drugs Product Portfolio
-
Table Novartis Pharma Ag Company Details
-
Table Novartis Pharma Ag IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Pharma Ag IBS-C Drugs Main Business and Markets Served
-
Table Novartis Pharma Ag IBS-C Drugs Product Portfolio
-
Table Nestle Company Details
-
Table Nestle IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nestle IBS-C Drugs Main Business and Markets Served
-
Table Nestle IBS-C Drugs Product Portfolio
-
Table Albireo Pharma Inc Company Details
-
Table Albireo Pharma Inc IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Albireo Pharma Inc IBS-C Drugs Main Business and Markets Served
-
Table Albireo Pharma Inc IBS-C Drugs Product Portfolio
-
Table Synergy Pharmaceuticals Company Details
-
Table Synergy Pharmaceuticals IBS-C Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synergy Pharmaceuticals IBS-C Drugs Main Business and Markets Served
-
Table Synergy Pharmaceuticals IBS-C Drugs Product Portfolio
-
Figure Global Linaclotide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lubiprostone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Osmotic Laxatives Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Stimulant Laxatives Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IBS-C Drugs Consumption Forecast by Country (2022-2028)
-
Table North America IBS-C Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe IBS-C Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC IBS-C Drugs Consumption Forecast by Country (2022-2028)
-
Figure China IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America IBS-C Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC IBS-C Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa IBS-C Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania IBS-C Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand IBS-C Drugs Consumption Forecast and Growth Rate (2022-2028)
-
